Dr Arthur Castelbaum M D - PA Philadelphia, Philadelphia 19107

Dr Arthur Castelbaum M D entered the industry of Internal Medicine Doctors in 2008 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 621111, which describes it as a Internal Medicine Doctors. For further clarification, the SIC classifies this business under the code 8011 and described it as a Internal Medicine Doctors. The business provides service to the B2C market.

To acquire more information, please contact Arthur Castelbaum by calling (215) 922-1556 during business hours. You can also write to the business’ Single Location at 1015 Chestnut St, Philadelphia, Pennsylvania PA 19107. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Dr Arthur Castelbaum M D
Representative: Arthur Castelbaum
Place of Business: 1015 Chestnut St, Philadelphia, PA 19107
Contact Number: (215) 922-1556
Type of Service: Internal Medicine Doctors
SIC Number: 8011
NAICS Number: 621111
Locality: Single Location
Market Type: B2C (Business to Consumer)
Began: 2008
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Dr Arthur Castelbaum M D is a company operating from Philadelphia, Pennsylvania providing professional Internal Medicine Doctors and relevant B2C variables. It was founded in 2008 and registered with the SIC code 8011 as Internal Medicine Doctors, and with the NAICS code 621111 as Internal Medicine Doctors.

With a current employee count of 1 to 4, Dr Arthur Castelbaum M D has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Arthur Castelbaum at (215) 922-1556 for related queries, or to locate its Single Location using the coordinates 39.95023,-75.157628.

The Single Location can also be found at the street address 1015 Chestnut St in Philadelphia, Pennsylvania 19107 and can be engaged online through the company website at , the company Twitter , and Facebook page .